DERMAPOLIS Medical Dermatology Center dr n. med. Edyta Gębska

Research site

Poland Ul. Św. Barbary 14, 41-500 Chorzow, Poland

1 trial recruiting
Hidradenitis · Neurodermatitis · Vitiligo
Adult patients

About Specializations

DERMAPOLIS Medical Dermatology Center dr n. med. Edyta Gębska in Chorzow, Poland specialises in clinical trials of conditions such as Hidradenitis, Neurodermatitis, Vitiligo, and other specialisations. This site conducts important research.

Main research areas of the site

Skin and Connective Tissue Diseases

DERMAPOLIS Medical Dermatology Center in Chorzow focuses on skin and connective tissue diseases, addressing chronic conditions such as Hidradenitis Suppurativa, Prurigo Nodularis and Vitiligo.

Hidradenitis Suppurativa
Prurigo Nodularis
Vitiligo

Current research evaluates the long‑term safety and tolerability of novel agents like sonelokimab and povorcitinib, aiming to expand effective treatment options for patients with severe dermatologic disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Św. Barbary 1441-500 ChorzowPoland

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 3

More sites in Chorzow Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Vitiligo+2

Recruiting

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Povorcitinib
Sponsor:Incyte Corp.

Contact Research Centre

Hidradenitis

Not recruiting

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites